Want to contact a District of Columbia Alimta lawyer? ...Get a free case evaluation from one of our District of Columbia Alimta lawyers now.

Alimta - News Articles

Lilly Oncology To Unveil More Than 50 Studies At Asco 2008
May 7, 2008
Medical News Today (press release), UK -
The company will present the latest research findings on ALIMTA® (pemetrexed for injection), GEMZAR® (gemcitabine HCl for injection), and enzastaurin, an investigational, oral, targeted therapy. The majority of the studies being presented are findings that support Lilly's leadership ...
PharmaLive: US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
Monday, June 02, 2008
PharmaLive.com (press release), PA -
HOUSTON, June 02, 2008 /PRNewswire/ -- Physicians affiliated with the US Oncology Research Network are presenting the results of their clinical research at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) held May 30 - June 3, 2008 ...
ABRAXANE(R) in Combination with Trastuzumab and Carboplatin Evaluated as First-Line Treatment for Patients with HER2-Positive Metastatic Breast Cancer
Jun 2, 2008
Business Wire (press release), CA -
CHICAGO--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of results from an ongoing single-arm, open-label, Phase II clinical trial evaluating ...
PharmaLive: Combination Therapy of Solvent-Free Abraxane and the Targeted Therapy Bevacizumab Evaluated as First-Line Treatment for Metastatic Breast Cancer
Monday, June 02, 2008
PharmaLive.com (press release), PA -
CHICAGO--(BUSINESS WIRE)--Jun 2, 2008 - Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of results from an ongoing single-arm, open-label, Phase II clinical trial evaluating solvent-free ABRAXANE(R) for Injectable Suspension (paclitaxel ...
US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
Monday, June 02, 2008
Earthtimes (press release), UK -
HOUSTON , June 2 -- Physicians affiliated with the US Oncology Research Network are presenting the results of their clinical research at the 44th Annual ...
RTTNews - Quick facts Articles, Positive EPS Surprises, News Analysis, Earnings, Audio News....
May 15, 2008
RTT News, NY -
(RTTNews) - Eli Lilly & Co. (LLY: News, Chart, Quote ) announced that it has planned to present the data from a pivotal non-small cell lung cancer or NSCLC clinical trial, which involved Alimta or pemetrexed for injection, at the 44th Annual Meeting of the ASCO in Chicago. ...
RTTNews - Breaking News, financial breaking News, Positive EPS Surprises, Stock research ....
May 15, 2008
RTT News, NY -
(RTTNews) - Based on the data from a non-small cell lung cancer study with ALIMTA (pemetrexed for injection), Eli Lilly & Co. (LLY: News, Chart, Quote ) on ...
Abdominal-Pelvic News|RTOG study: Weight, not diabetes, related to prostate cancer mortality | Source: Radiation Therapy Oncology Group (RTOG) | Radiology News | Radiology Articles | Medical Imaging News | Healthcare News
Tuesday, June 03, 2008
Medicexchange, UK -
Diabetic men with prostate cancer are no more likely to die from their cancer than are men who are not diabetic. However, increased body weight does increase the likelihood of prostate cancer-related death according to new research from the Radiation Therapy Oncology Group (RTOG) presented ...
Advances In Breast Cancer Treatment
Tuesday, June 03, 2008
Medical News Today (press release), UK -
Plenary and late-breaking studies that advance the treatment of both early and advanced breast cancer were released at a press briefing at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO). "We have a multitude of therapies for ...
Newswise Medical News | New Drug Cocktail Extends Lives of Patients with Advanced Breast Cancer
Tuesday, June 03, 2008
Newswise (press release) -
Newswise — Researchers using a new cocktail of cancer treatment drugs are reporting the best survival rate to date in patients with an aggressive type of advanced breast cancer. Results were announced at the 2008 meeting of the American Society of Clinical Oncology (ASCO) ...
My ASCO Fiasco - Pharmas Market with Mike Huckman - MSNBC.com
Tuesday, June 03, 2008
CNBC, NJ -
Two point seven million square feet! According to the web site for McCormick Place here in Chicago, that's the size of "the nation's largest convention ...
Smokers With Advanced Colon Cancer May Face Higher Odds Of Disease Recurrence
May 30, 2008
Science Daily (press release) -
ScienceDaily (May 30, 2008) — People with advanced colon cancer who have smoked cigarettes or used other tobacco products for many years may have an increased risk that their colon cancer will return, according to research by Dana-Farber Cancer Institute scientists to be presented ...
Chemotherapy Diminishes Fertility In Breast Cancer Patients, Study Suggests
May 30, 2008
Science Daily (press release) -
ScienceDaily (May 30, 2008) — Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve -- the capacity of the ovaries to provide eggs capable of being fertilized - compared to ...
Lung cancer patients fight stigma | U.S. | Reuters
May 30, 2008
Reuters -
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - "I'm sorry. You don't have breast cancer," the oncologist told Charmaine Atkenson. The 48-year-old mother of two had something far worse -- ...
Society for Translational Oncology Launches Updated Website - FOXBusiness.com
May 30, 2008
FOXBusiness -
CHICAGO, May 30, 2008 /PRNewswire via COMTEX/ ----The Society for Translational Oncology (STO) is pleased to announce the launch of its newly updated website, highlighting uniquely valuable video presentations for practicing oncologists. (Logo: http://www.newscom.com/cgi-bin/prnh/20080530/CLF025LOGO ...
Free Preview - WSJ.com
May 30, 2008
Wall Street Journal -
By MARILYN CHASE CHICAGO -- Leading US cancer scientists said that five years of flat federal funding of cancer research is threatening to undo major strides made against the disease. Nancy Davidson, president of the American Society of Clinical Oncology, said ...
AFP: US cancer researchers attack federal budget cuts
May 31, 2008
AFP -
CHICAGO (AFP) — Consistent reductions in US federal budget allocations for cancer research that have been implemented since 2003 threaten to undermine recent gains in the fight against the disease, scientists said. The warning came from about 30,000 prominent US ...
Chemo May Limit Fertility in Breast Cancer Survivors - washingtonpost.com
May 31, 2008
Washington Post, United States -
SATURDAY, May 31 (HealthDay News) -- Chemotherapy may reduce fertility in breast cancer survivors, according to a study led by researchers at Boston's ...
Health - Life & Style Home - smh.com.au
May 31, 2008
Sydney Morning Herald, Australia -
WOMEN who have low levels of vitamin D when they are diagnosed with breast cancer are almost twice as likely to see the cancer spread and 73 per cent more likely to die within 10 years, research has found. The findings, presented at the American Society of ...
What doctors don?t say about cancer - INQUIRER.net, Philippine News for Filipinos
May 31, 2008
Inquirer.net, Philippines -
SINCE 1995, cancer has been the third leading cause of death among Filipinos, after heart disease and stroke. It climbed to No. 3 from No. 5 in just a decade, according to the Department of Health (DOH). DOH data from 1920 to ...
Want to contact a District of Columbia Alimta lawyer? ...Get a free case evaluation from one of our District of Columbia Alimta lawyers now.

Pages:   1   2   3   4   5   6   ...   Next

AddThis Social Bookmark Button

 

Need An Alimta Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need An Alimta Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Alimta Case - Submit Your Information Below

Do you need legal assistance with your Alimta case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Alimta Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.